532523 announcements Biocon Ltd. announcements and dividends declared BSE
Biocon Ltd. Complete list of announcements declared & dividend announcements by Biocon Ltd. 532523
Biocon Ltd. 532523 listed on BSE and deals inAnnouncements and dividends declared by Biocon Ltd. 532523
Biocon Biologics gets USFDA nod for diabetes medication
Biocon Biologics has secured USFDA approval for Kirsty. Kirsty is an interchangeable biosimilar to NovoLog, used for diabetes treatment. It is a rapid-acting insulin analog. The medication will be available in prefilled pens and vials. This approval expand
Announcement as on 16 July 2025
Breakout Stocks: How to trade Biocon, RBL Bank & HDFC AMC that hit fresh 52-week high?
Indian market closed with a positive bias, as BSE Sensex and Nifty50 saw gains, led by auto, FMCG, realty, and IT sectors. Biocon, RBL Bank, and HDFC AMC hit fresh 52-week highs. Analysts suggest monitoring Biocon for a breakout above 425, RBL Bank for pro
Announcement as on 16 July 2025
Biocon among 11 stocks hitting 52-week high, rally up to 20% in a month
Sensex edged up 63 points, while 11 BSE 500 stocks hit 52-week highs, including Biocon, HDFC AMC, and Nippon Life, signaling strong momentum and bullish sentiment across key sectors.
Announcement as on 16 July 2025
Bullish on these 7 sectors; Biocon and Nykaa are two top picks: CA Rudramurthy BV
Expert CA Rudramurthy BV suggests a bullish stance. He recommends buying on dips, especially in pharma stocks like Glenmark, Laurus Labs, and Biocon. Consumer discretionary and FMCG sectors also present opportunities. PSU banks such as SBI and PNB look pro
Announcement as on 11 July 2025
Biocon Biologics gets UK MHRA nod for biosimilars Vevzuo, Evfraxy
Biocon Biologics Ltd has achieved a significant milestone. It has secured marketing authorizations in the UK for Vevzuo and Evfraxy. These are biosimilars of Denosumab. Vevzuo addresses skeletal events in adults with advanced malignancies. Evfraxy treats o
Announcement as on 07 July 2025
Announcements by Biocon Ltd. first page | Next page | Prev page |
532523 Biocon Ltd. current price & indicator signals
Recent prices of 532523 Biocon Ltd. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 30 Tue Dec 2025 | 390.40 | 389.60 to 392.80 | 0.04% | 0.83 times |
| 29 Mon Dec 2025 | 390.25 | 388.15 to 399.30 | -1.27% | 0.46 times |
| 26 Fri Dec 2025 | 395.25 | 394.05 to 401.00 | -0.7% | 0.36 times |
| 24 Wed Dec 2025 | 398.05 | 397.30 to 406.00 | -0.83% | 0.86 times |
| 23 Tue Dec 2025 | 401.40 | 398.85 to 403.70 | 0.59% | 0.88 times |
| 22 Mon Dec 2025 | 399.05 | 397.15 to 402.80 | 0.18% | 4 times |
| 19 Fri Dec 2025 | 398.35 | 393.50 to 401.55 | 1.58% | 1.07 times |
| 18 Thu Dec 2025 | 392.15 | 385.80 to 395.35 | 1.49% | 1.15 times |
| 17 Wed Dec 2025 | 386.40 | 383.90 to 388.50 | 0.45% | 0.22 times |
| 16 Tue Dec 2025 | 384.65 | 384.20 to 391.95 | -1.51% | 0.31 times |
| 15 Mon Dec 2025 | 390.55 | 383.70 to 391.60 | 1.01% | 0.68 times |
| 12 Fri Dec 2025 | 386.65 | 382.70 to 388.80 | 1.34% | 0.26 times |
Videos related to: 532523 announcements Biocon Ltd. announcements and dividends declared BSE
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- BSE Screeners
- BSE Daily Screener
- BSE Weekly Screener
- BSE Monthly Screener
- Support & Resistance
- BSE Shares Near Support
- BSE Shares Near Resistance


